1. Home
  2. BNR vs ACHV Comparison

BNR vs ACHV Comparison

Compare BNR & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

N/A

Current Price

$22.81

Market Cap

252.7M

Sector

Health Care

ML Signal

N/A

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

N/A

Current Price

$4.34

Market Cap

233.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNR
ACHV
Founded
2014
N/A
Country
China
United States
Employees
674
N/A
Industry
Medical Specialities
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
252.7M
233.7M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
BNR
ACHV
Price
$22.81
$4.34
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.50
AVG Volume (30 Days)
13.1K
327.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.33
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.32
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.18
$1.84
52 Week High
$41.72
$6.03

Technical Indicators

Market Signals
Indicator
BNR
ACHV
Relative Strength Index (RSI) 40.95 47.21
Support Level $7.99 $4.24
Resistance Level $24.23 $4.78
Average True Range (ATR) 2.07 0.22
MACD -0.41 0.00
Stochastic Oscillator 29.88 39.01

Price Performance

Historical Comparison
BNR
ACHV

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: